Polyadenylation-induced translation is an important regulatory mechanism during metazoan development. During Xenopus oocyte meiotic progression, polyadenylation-induced translation is regulated by CPEB, which is activated by phosphorylation. XGef, a guanine exchange factor, is a CPEB-interacting protein involved in the early steps of progesterone-stimulated oocyte maturation. We find that XGef influences early oocyte maturation by directly influencing CPEB function. XGef and CPEB interact during oogenesis and oocyte maturation and are present in a c-mos mRNP. Both proteins also interact directly in vitro. XGef overexpression increases the level of CPEB phosphorylated early during oocyte maturation and this directly correlates with increased Mos protein accumulation and acceleration of meiotic resumption. To exert this effect XGef must retain guanine exchange activity and the interaction with CPEB. Overexpression of a guanine exchange deficient version of XGef, which interacts with CPEB, does not enhance early CPEB phosphorylation. Overexpression of a version of XGef that has significantly reduced interaction with CPEB, but retains guanine exchange activity, decreases early CPEB phosphorylation and delays oocyte maturation. Injection of XGef antibodies into oocytes blocks progesterone-induced oocyte maturation and early CPEB phosphorylation. These findings indicate that XGef is involved in early CPEB activation and implicate GTPase signaling in this process.
Introduction
Polyadenylation-induced translation of stored maternal mRNAs is an important regulatory mechanism for ensuring appropriate spatial and temporal protein expression in the developing oocytes and embryos of many metazoans de Moor and Richter, 2001 ).
Essentially, mRNAs with a short poly (A) tail are translationally repressed, whereas those with a long poly (A) tail are translationally activated. The active modulation of poly (A) tail length results in the repression or activation of translation of the mRNA (Richter, 2000) . In Xenopus and mouse oocytes, mRNAs targeted for polyadenylation-induced translation contain a U-rich sequence, the cytoplasmic polyadenylation element (CPE), within the 3'UTR. This sequence is bound by CPEB, which, depending on the mRNA and activation state of CPEB, assists in maintenance of translational repression of mRNA or mediates polyadenylation-induced translation (Mendez and Richter, 2001 ).
During meiotic progression in Xenopus oocytes (oocyte maturation), polyadenylation-induced translation plays an important role in activation of the Mos/MAPK pathway (Sheets et al., 1995) .
Briefly, meiosis can be re-initiated by the action of progesterone on the oocyte membrane, most likely through a seven-transmembrane G protein coupled receptor (Zhu et al., 2003a; Zhu et al., 2003b) , with perhaps some effects mediated by a classical progesterone receptor (Bayaa et al., 2000; Tian et al., 2000) . Within minutes, there is a transient decrease in PKA activity (Nebreda and Ferby, 2000) . Through a not completely defined pathway, the decrease in PKA activity leads to the activation of CPEB and the polyadenylation-induced translation of stored c-mos mRNA, thus activating the Mos/MAPK pathway. This pathway converges with the Cdc25 pathway, which is also activated by the decrease in PKA activity, to activate stored maturation promoting factor (MPF), a complex of cyclin B1 and cdc2 (Tunquist and Maller, 2003) .
Activated MPF then directs a number of key meiotic events, including chromatin condensation and nuclear envelope breakdown, or GVBD (Sagata, 1997) .
XGef was initially identified in a yeast two-hybrid screen for proteins interacting with CPEB.
Functional analysis revealed that XGef is a guanine nucleotide exchange factor for Cdc42 in mammalian cells, and that it influences Xenopus oocyte maturation prior to or coincident with the polyadenylation of c-mos mRNA (Reverte et al., 2003) . The coincidence in timing of early CPEB activity and XGef influence on Mos protein accumulation suggests that XGef might influence c-mos mRNA polyadenylation by affecting CPEB activity. The current study was designed to examine the possibility that XGef might influence early CPEB activation during oocyte maturation.
CPEB activation in early oocyte maturation is regulated by phosphorylation. Serine 174 (S 174 ), and perhaps serine 180 (S 180 ), of CPEB are phosphorylated within two hours of progesterone stimulation (Mendez et al., 2000a) and this is clearly necessary for proper CPEB function.
Overexpression in oocytes of a version of CPEB containing alanine substitutions at S 174 and S
180
(CPEB AA), decreases the extent of polyadenylation of endogenous c-mos mRNA early during oocyte maturation (Charlesworth et al., 2004) , and completely blocks polyadenylation of an injected c-mos mRNA 3'UTR (Mendez et al., 2000a) . In addition, overexpression of CPEB AA prevents endogenous Mos protein accumulation. This, perhaps in concert with the perturbation of expression of other proteins, leads to a complete block of oocyte maturation (Mendez et al., 2000a) .
We have now determined that XGef has a direct influence on early CPEB activation. XGef is present in a complex containing CPEB and c-mos mRNA in prophase I oocytes and oocytes undergoing meiosis. Overexpression of XGef increases the level of early-phosphorylated CPEB, and this directly correlates with an increase in Mos protein levels and acceleration of oocyte maturation. To determine how XGef might influence CPEB phosphorylation, we generated several mutated versions of XGef and tested their influence on early CPEB phosphorylation, Mos synthesis and oocyte maturation. Using a version of XGef with very reduced binding to CPEB, we found that their interaction is necessary for the influence of XGef on CPEB phosphorylation. Using an exchange deficient version of XGef, we provide data that strongly suggests that XGef exchange factor activity is needed for the influence of XGef on early CPEB phosphorylation, thus implicating GTPase activity in this event. We also demonstrated that the amino-terminal 50 amino acids and the DH domain of XGef are each involved in interacting with CPEB. Potential mechanisms for XGef mediation of early CPEB phosphorylation are discussed.
Materials and Methods

Plasmid constructs
The inserts from pACT2-XGef (1-461), pACT2-XGef (33-465), pACT2-XGef (65-465), pACT2-XGef (235-465), pACT2-XGef (268-465), pACT2-XGef (268-360), pACT2-XGef (1-360), pACT2-XGef (1-267), pACT2-XGef (65-360), pACT2-XGef (1-234), and pACT2-XGef (65-234) were removed by digestion with NcoI and XhoI and subcloned into the pHA-SP vector (Reverte et al., 2003) , digested with the same enzymes, to generate pSP6HA-XGef deletion mutants. To generate pSP6-GST, pGST-CPEB-SP (Reverte et al., 2003) was digested with EcoRI and BglII to remove the CPEB insert, blunt ended with Mung Bean nuclease and ligated. pSP6GST-XGef (1-465) was generated by PCR amplification of pGEX2T-XGef (1-465) with primers SP6GST12For (5'-CCGCTCGAGTCAGAGCAGGGAGCAACTCC-3') and SP6GST12Rev (5'-CCGCTCGAGTCAGAGCAGGGAGCAACTCC-3'). The product was then digested with EcoRI and XhoI and ligated into the pSP64-S vector cut with the same enzymes.
To generate internal deletions the Quick Change Multi Site Directed Mutagenesis Kit (Stratagene, La Jolla, CA) was used following the manufacturer's instructions. The oligonucleotides used for pSP6HA-XGef (∆65-234) were dhfor1 (5'-CCATGGCTTGCTC TCGAGAATGAGCGGCACCTCCGAAGG-3') and dhrev1 (5'-CTCGAGAGCAAGCCA TGGTTTGGCCGTTGTCAGTCTCTTGCGC-3'), for pSP6HA-XGef (∆50-234) were dhfor7
(5'-GGAACGTTGTCCATGGCTTGCTCTCGAGAATGAGCGGC ACCTCC-3') and dhrev7
(5'-GCAAGCCATGGACAACGTTCCTCTGGTTCCTCAACCAACTCTG-3') and for pSP6HA-XGef (∆50-77) were dhfor8 (5'-GGAACGTTGTCCATGGCATGACGTTTTCCG CGCTCGATGCGG-3') and dhrev8 (5'-GAAAACGTCATGCCATGGACAACGTCC CTCTGGTTCCTCAACC-3') using pSP6HA-XGef as the template. pAX142, pAX142-cdc42(12V), pAX142-dbl-HA1 and pAX142-XGEF have been described previously (Whitehead et al., 1999; Reverte et al., 2003) . pAX142-XGef(65-360) was made by inserting the EcoR1 fragment of pSP6HA-XGef(65-360) into EcoRI digested pAX142. The reporter construct utilized in the luciferase-coupled transcriptional assays (SREm) 2 has been described previously (Westwick et al., 1998) . pCMVnlac encodes the β-galactosidase gene under the control of the CMV promoter (Whitehead et al., 1999) .
Production and purification of recombinant proteins
The glutathione S-transferase-XGef (GST-XGef) fusion protein was expressed in E. coli (BL21) by induction for 16 h with 2 mM IPTG at 20° C, purified on glutathione-sepharose 4B beads (Amersham Pharmacia, Piscataway, NJ), and concentrated in PBS with 0.1% Triton X according to directions from the manufacturer.
Expression of histidine (6x)-tagged CPEB (His-CPEB) was induced in BL21 cells for 3 h with 4 mM IPTG at 20° C and purified using nickel-agarose beads in binding buffer (20 mM Tris-HCl pH 7.9, 0.5 M NaCl, 5 mM imidazole and 0.25% Tween 20). After extensively washing in 20 mM Tris-HCl pH 7.9, 0.5 M NaCl, 60 mM imidazole, the protein tethered to the beads was saved in binding buffer at 4° C. If required, His-CPEB elution was performed with 20 mM Tris-HCl pH 7.9, 0.5 M NaCl, 1 M imidazole.
RNA synthesis Plasmids were linearized and used as templates for in vitro transcription with the SP6 or T7 mMessage mMachine kit (Ambion, Austin, TX) as previously described (Reverte et al., 2003) .
Oocyte Culture and Microinjections
Oocytes from nonprimed Xenopus laevis adult females (Nasco, Fort Atkinson, WI) were obtained by digestion in 1X Barth's saline using 2 mg/ml collagenase (type II, Sigma, St. Louis, MI) and 0.6 U/ml dispase (Roche Diagnostics Corporation, Indianapolis, IN) for 1.5 hours. Prophase I oocytes were selected and cultured in 1X Barth's saline or OR2 medium with 10 µg/ml Streptomycin (Invitrogen, Carlsbad, CA). Oocytes were injected as described previously (Reverte et al., 2001 ). The injected oocytes were then transferred to fresh 1X Barth's or OR2 medium and incubated 15-20 hours at 18°C.
Protein Extracts and Immunoblot Analysis
To analyze the biochemical markers of oocyte maturation as well as for in vitro CPEB phosphorylation assays, extracts from prophase I and maturing oocytes were prepared by homogenization with 3 µl per oocyte extraction buffer (20 mM Hepes pH 7.5, 100 mM NaCl, 10 mM β-glycerophosphate, 5 mM EGTA, 5 mM MgCl 2 , 100 mM sucrose, 2 mM NaVaO 4 , 20 mM NaF, 1 mM PMSF, 1 mM DTT, 2 µM okadaic acid) with protease inhibitors (5 ng/µl leupeptin and 10 ng/µl each chymostatin, pepstatin, and aprotinin) and centrifugation (12.5 krpm, 4°C, 20 min). The clear cytoplasmic layer was removed and incubated with cytochalasin B and centrifuged again for 10 min. For protein interaction assays, extracts from prophase I oocytes were prepared as described (Reverte et al., 2003) . For immunoprecipitation assays, extracts were prepared by pipetting oocytes up and down in 10 µl per oocyte 1X NET buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% NP-40, 1 mM EDTA). In both cases, clarified extracts were obtained by centrifugation (14 krpm, 4°C, 10 minutes).
Immunoblotting was carried out after separation of protein extracts by 10-15% SDS PAGE (Laemmli, 1970) or electrophoresis in 12.5-15% Anderson gels (Anderson et al., 1973 ) and transfer to PVDF membranes (Millipore, Billerica, MA). Membranes were probed with the antibodies indicated, and bound antibodies were detected by ECL (Amersham Pharmacia), as described (Reverte et al., 2003) . Guinea pig polyclonal anti-CPEB antibody was produced by injection of gel purified His-CPEB into guinea pigs (Covance Research Products, Denver, PA) and used at a 1:3000 dilution. Anti-MAPK antibody (New England Biolabs, Beverly, MA) was used at a 1:1000 dilution. Horse radish peroxidase (HRP)-conjugated anti-guinea pig IgG (Santa Cruz Biotechnology, Santa Cruz, CA) was used at a 1:7,000 dilution.
H1 Kinase assays
To assay MPF activity in oocytes, cytoplasmic extracts were prepared as described above. (Ferby et al., 1999; Sigma) .
Reactions were performed at room temperature for 15 min, stopped by the addition of sample loading buffer and analyzed by 12.5% SDS-PAGE followed by autoradiography.
Protein-protein interaction assays
The binding of HA-XGef and GST-CPEB tethered to glutathione-beads was carried out essentially as described (Reverte et al., 2003) with minor modifications. Oocytes were injected with HA or GST tagged mRNAs and incubated overnight to allow translation and protein accumulation (Reverte et al., 2001) . For the modified GST affinity precipitation assay, extracts from oocytes expressing individually either an HA or GST tagged protein were analyzed by immunoblotting with anti-HA or anti-GST antibodies, respectively, followed by densitometry. Extract containing equivalent amounts of GST or GST-CPEB was then pre-incubated with glutathione Sepharose beads. Oocyte extract containing equivalent amounts of the various HA-tagged proteins was added to the GST or GST-CPEB beads. To maintain similar overall protein concentrations in each binding assay, extract from non-expressing oocytes was added to samples containing lower volumes of HA-tagged protein expressing extract. Binding conditions, washing and resuspension of the beads, and immunoblot analysis of the bound samples were performed as described previously (Reverte et al., 2003) .
In vitro binding assays The in vitro binding assay for purified, bacterially expressed GSTXGef (0.5-1 µg immobilized on glutathione-sepharose) and purified, bacterially expressed His-CPEB (1.5-2.5 µg) was carried out in binding buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.25% Triton X and protease inhibitors) and 0.5% BSA for 20 min at 4°C. Beads were washed with the same buffer plus 200 mM NaCl, and samples were analyzed by 10% SDS-PAGE and immunoblotting using guinea pig anti-CPEB antibody.
Co-immunoprecipitation of endogenous CPEB and endogenous XGef Cleared oocyte extracts obtained as described above were first precleared using IgG-coated rProtein G Agarose beads (Invitrogen). XGef was immunoprecipitated from extracts using anti-XGef antibody and rProtein-G Agarose beads for 4 hours at 4°C and the immunoprecipitates were extensively washed with 1X NET buffer at room temperature and analyzed by SDS-PAGE and immunoblotting. As a control, IgG (normal rabbit IgG, Santa Cruz Biotechnology) coated rProtein G agarose beads were used.
Immunoprecipitation and RT-PCR Protein extract from 300 oocytes was used for immunoprecipitation as describe above with minor modifications. After pre-clearing, the resulting lysates were divided into three fractions. Each fraction was mixed with beads plus either (i) non-specific IgG from rabbit, (ii) rabbit anti-XGef serum, or (iii) rabbit anti-CPEB serum. After immunoprecipitation and extensive washing, immune complexes were eluted from the beads with 2X SDS loading buffer. RNA was phenol/chloroform-deproteinized and then ethanol-precipitated. First strand cDNA was synthesized using SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen). In the second step, PCR was performed using Platinum Taq DNA polymerase (Invitrogen) and c-mos mRNA (Reverte et al., 2003) or β-actin mRNA specific primers (sense 5'-GCACGAGCCGCATAGAAAGGA-3' and antisense 5'-GCTTCTGTGAGCAGCACTGG-3'). Reamplification of PCR products was performed using the same primers as in the initial amplification. PCR products were resolved on a 1% agarose gel and visualized using ethidium bromide staining. 
In vitro CPEB phosphorylation assay
Methods for Protein Sequence Analysis by LC-MS/MS
Protein bands excised from gels were subjected to a modified in-gel trypsin digestion procedure (Shevchenko et al., 1996) .
Phosphopeptide analysis was performed by the Taplin Biological Mass Spectrometry Facility (Harvard Medical School, Boston, MA). Briefly, tryptic peptides were separated by nano-scale reverse-phase HPLC (Peng and Gygi, 2001 ), subjected to electro-spray ionization and loaded into an LCQ DECAXP plus ion-trap mass spectrometer (ThermoFinnigan, San Jose, CA).
Eluting peptides were detected, isolated and fragmented to produce a tandem mass-spectrum of specific fragment ions for each peptide. Peptide sequences (and hence protein identity) were determined by matching acquired peptide fragmentation patterns against fragmentation patterns from a protein database using the software program, Sequest (ThermoFinnigan, San Jose, CA; (Eng et al., 1994) . Modification of 80 mass units to serine, threonine, and tyrosine where included in the database searches to determine phosphopeptides. Each phosphopeptide that was determined by the Sequest program was also manually inspected in ensure confidence.
Transient expression reporter gene assays COS-7 cells were maintained in Dulbecco's modified Eagle medium (DMEM; high glucose) supplemented with 10% fetal bovine serum (Sigma). For transient expression reporter gene assays, COS-7 cells were transfected by DEAEdextran as described previously (Whitehead et al., 1995) . Cells were allowed to recover for 30 h, and were then starved in DMEM that was supplemented with 0.5% serum for 14 h before lysate preparation. Analysis of luciferase expression was as described previously with enhanced chemiluminescent reagents and a Monolight 3010 luminometer (Analytical luminescence, San Diego, CA; Westwick et al., 1998) . β-galactosidase activity was determined using Lumi-Gal substrate (Lumigen, Southfield, MI) according to the manufacturer's instructions. All assays were performed in triplicate.
Results
XGef and CPEB interact in vivo and interact directly in vitro
XGef overexpression in oocytes accelerates progesterone-stimulated polyadenylation and accumulation of c-mos mRNA (Reverte et al., 2003) . XGef could achieve this by influencing the early activity of CPEB, perhaps through interaction with CPEB in oocytes. To address this possibility, we extended our previous studies showing that recombinant XGef interacts with endogenous CPEB and vice-versa (Reverte et al., 2003) and have demonstrated that endogenous XGef interacts with endogenous CPEB during oogenesis and oocyte maturation ( Figure 1 ). XGef antibody co-immunoprecipitated CPEB from staged oocytes and oocytes undergoing progesterone-stimulated meiotic maturation ( Figure 1A ). XGef-CPEB interaction appeared to be stronger in stage III oocytes than in stage VI oocytes ( Figure 1A , compare lanes 1 and 4). The level of interaction remained relatively consistent from stage VI oocytes through 100% GVBD oocytes ( Figure 1 , lanes 4-12). During oocyte maturation, 70-90% of CPEB is degraded (Reverte et al., 2001 ). This is evident as a decrease in CPEB signal as meiosis proceeds ( Figure   1A , second panel, lanes 5-11) and is most apparent in extracts from oocytes 1 hour after 100% GVBD ( Figure 1A , second panel, lane 12). With a decreasing amount of CPEB, the amount that can be immunoprecipitated by XGef also obviously decreases, and is barely detectable one hour after GVBD ( Figure 1A , top panel, lanes 5-12). We believe, however, that this decrease in signal 1 hour after 100% GVBD is only due to the great decrease in CPEB amount, because when we use five times more of this extract for immunoprecipitation, we readily detect CPEB ( Figure 1A , top panel, lane 13).
The observation that XGef and CPEB can be co-immunoprecipitated in the absence ( Figure 1A , lanes 1-4) or presence (lanes 5-13) of progesterone indicates that hormone induction is not required for their interaction. Moreover, the interaction between endogenous XGef and endogenous CPEB is not mediated by their mutual binding to RNA, as the interaction is maintained in immunoprecipitation reactions containing RNAse A ( Figure 1B , compare lanes 2 and 3).
We examined whether XGef and CPEB interact directly using an in vitro pulldown assay. Using 
XGef and CPEB are components of a c-mos mRNP in prophase I oocytes and early maturing oocytes
We next wondered whether XGef might interact with CPEB that was also bound to mRNA. To address this, we used RT-PCR to ask whether c-mos mRNA was present in XGef protein complexes immunoprecipitated from prophase I oocytes and oocytes in the early stages of meiotic resumption (Figure 3 ). RNA extracted from the immune complexes was analyzed by
RT-PCR using c-mos mRNA specific primers (Reverte et al., 2003) . indicate that XGef interacts with CPEB bound to c-mos mRNA in both prophase I oocytes and in oocytes in early meiosis, reinforcing the possibility that XGef associates with the pool of CPEB that is involved in the regulation of c-mos mRNA polyadenylation-induced translation.
The influence of XGef on oocyte maturation requires an interaction with CPEB
Our finding that XGef influences oocyte maturation prior to or at c-mos mRNA polyadenylation (Reverte et al., 2003) , combined with our current demonstration of a direct interaction between CPEB and XGef strongly suggests that XGef has an influence on the function of CPEB in oocyte maturation. To examine this more closely, we asked whether the interaction between XGef and CPEB was necessary for the influence of XGef on oocyte maturation. To do this, we first needed to map the domain of XGef required for interaction with GST-CPEB (Figure 4) . From this information, we generated a version of XGef with very reduced binding to CPEB that was still capable of guanine nucleotide exchange ( Figure 5 ). We then overexpressed this version of XGef in oocytes and assessed its influence on progesterone-induced oocyte maturation ( Figure   6 ).
Both the amino terminus and DH domain of XGef interact with CPEB
Wild-type and deletion mutant versions of HA-tagged XGef (HA-XGef) were overexpressed in oocytes and tested for their ability to interact with oocyte overexpressed GST-CPEB in glutathione agarose pull-down assays (Figure 4) . A summary of our results in Figure 4A Figure 4D , lane 6). We suspect that, as found in other GEFs (Schmidt and Hall, 2002) , there may be an influence of the amino and carboxy terminal domains on the DH-PH domain, such that, when they are absent, the DH domain can only interact with CPEB very weakly.
XGef(65-360) can function as an exchange factor
An important requirement for our subsequent assays was that we generate a mutated version of XGef with diminished interaction with CPEB that was still able to function as a guanine nucleotide exchange factor. We confirmed that HA-XGef in COS-7 cells (Westwick et al., 1998) . Consistent with our previous results, a constitutively activated version of Cdc42 [Cdc42(12V)], and an activated version of the RhoGEF Dbl (Dbl-HA1), stimulated this reporter by 11 and 12-fold respectively when compared to vector controls.
In comparison, both HA-XGef and HA-XGef (65-360) showed a reduced but consistent ability to activate the reporter (9-fold and 7-fold respectively). These results suggest that HA-XGef and HA-XGef (65-360) have roughly equivalent activity in vivo, and are consistent with our previous observation that XGef is a weaker activator of mammalian Cdc42 than Dbl (Reverte et al., 2003) .
Interaction between XGef and CPEB is necessary for the influence of XGef overexpression on oocyte maturation
To determine if the interaction between XGef and CPEB is required for the influence of XGef on oocyte maturation, we overexpressed HA-XGef, HA-Globin, HA-XGef (65-360) and HAXGef(∆65-234) in oocytes ( Figure 6 ), and induced meiotic maturation with progesterone. The time to GVBD was assessed to monitor the influence of these proteins on meiotic progression ( Figure 6A ; results showing analysis of some biochemical markers of meiosis in these oocytes are presented in Figure 8B ). Overexpressed HA-XGef(∆65-234), which lacks the DH domain and therefore exchange factor activity, has no influence on maturation compared with HAGlobin overexpression, as observed previously (Reverte et al., 2003) . Overexpression of HAXGef(65-360) significantly delays GVBD (P value <0.01) in comparison with HA-Globin ( Figure 6B ), whereas overexpression of wild-type HA-XGef significantly accelerates GVBD (P value <0.01), as observed previously (Reverte et al., 2003) . These results strongly suggest that the interaction between XGef and CPEB is involved in the role of XGef in stimulating meiosis.
XGef overexpression enhances early phosphorylation of CPEB during progesteronestimulated oocyte maturation
Because early activation of CPEB by phosphorylation is involved in the polyadenylation-induced translation of c-mos mRNA (Mendez et al., 2000a; Charlesworth et al., 2004) , we examined the possibility that XGef overexpression might influence early CPEB phosphorylation, and therefore early CPEB activation. To do this, we used the in vitro phosphorylation assay developed by Mendez et al. (2000a) that recapitulates the early activating phosphorylation of endogenous CPEB. We monitored the timing, extent and pattern of early CPEB phosphorylation in the presence and absence of overexpressed HA-XGef (Figure 7 ).
We first confirmed that our early stage oocyte extracts recapitulate early phosphorylation of CPEB by comparing in vitro phosphorylation assays using extracts from prophase I oocytes and extracts from oocytes collected 2.5 hours (early maturing oocytes) and 6 hours (matured, GVBD oocytes) after progesterone stimulation ( Figure 7A ). Extracts were incubated with His-CPEB WT tethered to beads in the presence of [γ-32 P]ATP. SDS-PAGE and autoradiography of the bead bound material revealed that His-CPEB WT is phosphorylated in early maturing oocytes at 2.5 hours, and is phosphorylated to a greater extent in GVBD oocytes at 6 hrs ( Figure 7A , top panel). This pattern parallels the early and late phosphorylation of endogenous CPEB ( Figure   7A , third panel and Mendez et al., 2000a) . CPEB immunoblots reveal the typical mobility shift of endogenous CPEB at GVBD, due to phosphorylation on multiple sites (Paris et al., 1991; Mendez et al., 2002) . Late phosphorylation of CPEB and the mobility shift were coincident with the activation of MPF, revealed by complete dephosphorylation of Cdc2 and histone H1 kinase activity only at GVBD ( Figure 7A , two bottom panels), as expected (de Moor and Richter, 1997; Mendez et al., 2002) . Notably, phosphorylation of His-CPEB at 2.5 hours coincided with the appearance of a low level of Mos protein and pMAPK. The further increase in Mos protein and pMAPK levels at GVBD is due to both a positive feedback loop (Howard et al., 1999 ) and stabilization of Mos protein (Nebreda et al., 1995) .
To examine the influence of XGef on early CPEB phosphorylation, HA-XGef was overexpressed in oocytes and then protein extracts from oocytes collected throughout the early stages of progesterone-stimulated oocyte maturation were used in in vitro phosphorylation assays When we analyzed these samples much more closely using phosphopeptide analysis, we found that the phosphorylation pattern of His-CPEB incubated with extracts from HA-XGef overexpressing oocytes was exactly the same as that obtained for His-CPEB incubated with extracts from HA-Globin overexpressing oocytes, indicating that XGef overexpression does not lead to an aberrant pattern of His-CPEB phosphorylation. Importantly, using the more direct method of tandem mass spectrometry of peptide fragment ions, we confirmed previous results indicating that S 174 is first phosphorylated 2.5 hours after progesterone induction (Mendez et al., 2000a) . In contrast, S 180 is not phosphorylated to the same extent as S
174
: the relative amount of phosphorylated versus non-phosphorylated S 174 was about 1:2, whereas for S 180 , this ratio was about 1:50. Previous work had suggested that S 180 might also be a site for regulatory phosphorylation of CPEB, based on proximity to S 174 and the similarity of the immediately surrounding sequence (Mendez et al., 2000a) , however our data suggest that this might not be the case. We conclude from these phosphorylation studies that His-XGef overexpression leads to an increase in the level of S 174 phosphorylated CPEB, a modification that has been demonstrated to be vital for the early activation of endogenous CPEB (Mendez et al., 2000a) .
XGef exchange factor activity and an interaction between XGef and CPEB are involved in the early phosphorylation of CPEB
To extend these studies, we assayed the effect of overexpressing HA-XGef(∆65-234) and HAXGef(65-360) on early CPEB phosphorylation (Figure 8 ). We found that exchange deficient 
XGef antibody blocks early phosphorylation of CPEB
Because XGef antibody can block c-mos mRNA polyadenylation, Mos protein accumulation and progesterone-induced oocyte maturation (Reverte et al., 2003) , we wondered whether XGef antibody could also block early CPEB phosphorylation ( Figure 8C ). As previously reported, anti-XGef antibody injection completely blocked oocyte maturation, whereas maturation was not affected when oocytes were injected with the same quantity of nonspecific rabbit anti-rat IgG ( Figure 8C , top panel and Reverte et al., 2003) . Extracts from these sets of oocytes, injected with either XGef or IgG antibodies, were used in in vitro phosphorylation assays. Notably, there was no phosphorylation of His-CPEB in early meiotic extracts when the oocytes were injected with
XGef antibody prior to progesterone induction. Non-specific IgG, in contrast, did not interfere with early phosphorylation of His-CPEB ( Figure 8C , compare lane 4 with lane 2). An important aspect of this experiment is that the injected XGef antibody is presumably blocking the function of endogenous XGef (see also Reverte et al., 2003) . We conclude that perturbation of endogenous XGef function, as well as overexpression of recombinant XGef, influences the early activating phosphorylation of CPEB.
Discussion
XGef is a Rho-family G-protein that interacts with CPEB and is involved in progesteronestimulated meiotic maturation in Xenopus oocytes prior to the polyadenylation of c-mos mRNA (Reverte et al., 2003) . The timing of XGef function correlates with a requirement for CPEB activity in regulating c-mos mRNA polyadenylation. In this study, we therefore explored the role of XGef in early CPEB function in the Mos/MAPK pathway, which is activated by progesterone and necessary for timely oocyte maturation. We found that XGef interacts with CPEB throughout oogenesis and oocyte maturation, and directly interacts with CPEB in vitro. In prophase I oocytes and oocytes in the early stages of meiosis, XGef and CPEB are present in a complex that also contains c-mos mRNA, suggesting that XGef is involved in a functional CPEB protein complex. To determine if the XGef-CPEB interaction is required for the role of CPEB in progesterone-stimulated oocyte maturation, we mapped the XGef domains required for interaction with CPEB. We found that the amino-terminal 50 amino acids and the DH domain of XGef are each capable of facilitating the interaction with CPEB. We also identified a version of
XGef ] with very reduced binding to CPEB that retains exchange factor activity.
Interestingly, this mutant acts in a dominant negative fashion when expressed in ovo, significantly delaying the onset of progesterone-stimulated GVBD. This result confirms that the interaction between XGef and CPEB is required for the influence of XGef on oocyte maturation.
Because early CPEB phosphorylation is reported to be necessary for early CPEB activity in cmos mRNA polyadenylation, we examined the potential influence of XGef overexpression on early CPEB phosphorylation. We found that wild-type XGef overexpression increases the level of S 174 phosphorylated CPEB early during meiotic maturation. In addition, an exchange deficient version of XGef [XGef(∆65-234)] does not influence early CPEB phosphorylation, whereas a version of XGef with greatly reduced binding to CPEB, significantly delays early CPEB phosphorylation. Notably, XGef antibody injection prevents early CPEB phosphorylation and blocks progesterone-induced oocyte maturation, presumably by blocking endogenous XGef function. We conclude from these studies that XGef mediates the early, activating phosphorylation of CPEB.
We observed a direct correlation between the level of early CPEB phosphorylation, Mos protein accumulation and the time to 50% GVBD in control oocytes and oocytes overexpressing various versions of XGef. Although this is the first time this correlation has been extensively documented, it is not surprising given the established role of CPEB in regulating the early polyadenylation-induced translation of c-mos mRNA (Stebbins-Boaz et al., 1996) , and the role of the Mos/MAPK pathway in timely meiotic progression (Fisher et al., 1999; Gross et al., 2000) . Presumably, elevating early phosphorylated CPEB levels by overexpression of XGef results in increasing the amount of activated CPEB available to recruit more polyadenylation complexes to mRNA (Mendez et al., 2000b) , leading to an increase in polyadenylation-induced translation of c-mos mRNA and stimulation of the Mos/MAPK pathway. In support of this, we previously demonstrated that XGef overexpression correlates with earlier c-mos mRNA poly (A) tail elongation and earlier achievement of maximal poly (A) tail length for the c-mos mRNA compared with controls (Reverte et al., 2003) . Earlier appearance of Mos protein paralleled this earlier polyadenylation of c-mos mRNA (Reverte et al., 2003) . It also follows that lower levels of phosphorylated CPEB would result in a lower degree of activation of polyadenylation-induced translation, and, in fact, we observe lower levels of Mos protein in samples with lower levels of early-phosphorylated CPEB. Given the importance of the Mos/MAPK pathway in triggering events of meiotic maturation (Fisher et al., 1999; Gross et al., 2000; Palmer and Nebreda, 2000) , the effects we see on meiosis are most likely due to the influence of XGef perturbation on Mos protein levels, however it is certainly possible that the polyadenylation-induced translation of other mRNAs is influenced by the increase in CPEB activity, and that these proteins might also impinge upon the timeliness of GVBD (Ferby et al., 1999; Charlesworth et al., 2004) .
The finding that XGef is found in a CPEB protein/c-mos mRNA mRNP in prophase I oocytes and oocytes undergoing meiosis, yet the influence of XGef on CPEB phosphorylation is only apparent around two hours after progesterone induction, indicates a requirement for a progesterone-stimulated event. Further support for this requirement comes from the observation that XGef overexpression increases the level of phosphorylated CPEB, but does not cause CPEB to be phosphorylated earlier than normal during oocyte maturation. Progesterone stimulation may activate CPEB-bound XGef for nucleotide exchange on a G-protein by stimulating a regulatory domain of XGef, as seen with the activation of the exchange factor Vav (Aghazadeh et al., 2000) . Another possibility is that progesterone stimulation activates an unidentified XGef binding protein required for stimulation of XGef nucleotide exchange activity. For example, activated Gα 13 , released after stimulation with LPA or thrombin, binds to and activates the exchange factor activity of p115 RhoGEF in COS cells (Hart et al., 1998) . Alternatively, progesterone stimulation may activate a pathway that works in parallel to or downstream of XGef mediated GTPase activation to regulate the kinase or conditions necessary for CPEB phosphorylation. Certainly, given its proposed role in early CPEB phosphorylation (Mendez et al., 2000a) , Aurora A kinase is a potential candidate for a kinase that might be acting in parallel to or downstream of XGef. However, the demonstration by several groups that Aurora A kinase is not activated until GVBD, and that it in fact requires MPF for activation (Frank-Vaillant et al., 2000; Castro et al., 2003; Ma et al., 2003; Maton et al., 2003) raises the distinct possibility that Aurora A is not the endogenous kinase responsible for early phosphorylation of CPEB.
Unfortunately, because of the paucity of information on the events occurring between the decrease in PKA activity and activation of CPEB, there are few clues as to prospective proteins that may be involved in the XGef influenced pathway. We are therefore currently attempting to identify these proteins.
When we overexpress wildtype XGef we are essentially doubling the concentration of XGef within the oocyte (data not shown). The resulting increase in CPEB phosphorylation and Mos protein levels suggests that there is an excess of suitable but stored CPEB in the cell that is easily recruited into an activated CPEB pool. The presence of a reserve CPEB pool has also been observed in experiments demonstrating that mRNAs containing a CPE are translationally repressed when injected into prophase oocytes (de Moor and Richter, 1999; Barkoff et al., 2000) .
Our observation also suggests that the endogenous concentration of XGef is limiting relative to the amount of CPEB in the oocyte. This proposal is supported by the fact that there is 3ng of CPEB for every 1ng of XGef per oocyte (Hake and Richter, 1994; Reverte et al., 2003) . This set of observations, combined with the likelihood that XGef (∆65-234) does not physically interact with a GTPase, provide a possible explanation for why XGef(∆65-234) does not function in a dominant negative fashion. Perhaps, overexpressed XGef(∆65-234) interacts with the excess pool of CPEB, but the absence of a DH domain prevents it from interacting with a GTPase; the DH domain is critical for GTPase interaction in a number of GEFs (Aghazadeh et al., 1998; Liu et al., 1998; Worthylake et al., 2000) . The XGef(∆65-234): CPEB complex is not therefore recruited to the GTPase: kinase complex (see below) and no increase in phosphorylation of this particular CPEB molecule occurs. The remaining complexes of wildtype XGef and CPEB and their access to available GTPase are uninterrupted, and CPEB phosphorylation proceeds normally.
Our finding that the interaction between XGef and CPEB is necessary for the influence of XGef on CPEB phosphorylation can be interpreted two ways. One possibility is that the interaction is necessary for XGef to appropriately activate a GTPase. Regulatory interactions between GEFs and auxiliary proteins have been shown to influence both the temporal and spatial activation of GTPases (Krendel et al., 2002; Schmidt and Hall, 2002) . Support for this possibility comes from our observations with the CPEB interaction impaired XGef mutant, XGef(65-360), which still functions as an exchange factor for Cdc42 in mammalian cells, yet delays early CPEB phosphorylation. Although XGef(65-360) probably can function as an exchange factor in oocytes (work in progress, Martínez and Hake), the interaction with CPEB may be required for the appropriate temporal or spatial activation of a GTPase in relation to its downstream targets.
Proper activation of these targets would be required for the subsequent phosphorylation of CPEB. Alternatively, the interaction between XGef and CPEB may help target CPEB for phosphorylation by influencing recruitment of a kinase or accessibility of CPEB to an activated kinase. This is supported by the fact that XGef(65-360) can function as a dominant negative mutation, significantly decreasing the level of phosphorylated CPEB. The dominant negative effect might be achieved by preferential association of XGef(65-360) with components necessary for CPEB phosphorylation, thereby preventing access to these components by WT-XGef: CPEB complexes.
These two scenarios, that the XGef:CPEB interaction is necessary either for GTPase activation or for proper targeting of CPEB for phosphorylation, are not mutually exclusive, and there is precedent for signaling complexes that contain or recruit substrate, GEF, G-protein and kinase to the same location (Li et al., 2003) . Based on our data, one possible model is that XGef, associated with a CPEB mRNP, recruits a Rho-family G-protein and a kinase. During progesterone-stimulated oocyte maturation, the G-protein, activated by XGef, may then activate a kinase that phosphorylates CPEB, thus triggering polyadenylation-induced translation. A functional interaction between XGef and CPEB may not in fact be limited to Xenopus oocytes: Drosophila CG8606, which has 39% amino acid similarity with XGef (Reverte et al., 2003) , interacts with a neuronal CPEB isoform from Drosophila (Si et al., 2003) . We are currently working to identify the cognate G-protein for XGef, as well as additional components of the XGef-CPEB protein complex. Activation of (SREM) 2 -driven luciferase expression by . NIH 3T3 cells were transiently transfected with 2.5 µg of the indicated constructs along with the reporter construct (SREm) 2 -luciferase (2.5 µg), and pCMVnlac (0.5 µg) as an internal control for transfection efficiency and growth inhibition. Luciferase and β-galactosidase activity were measured and expressed as fold activation relative to the level of activation seen with the vector control.
Figure Legends
Luciferase activity was then standardized relative to the β-galactosidase activity. Data shown are representative of three independent experiments performed on triplicate plates. Samples were assayed for MPF activity using an histone HI kinase assay (pH1, 32 anti-pMAPK and anti-Cdc2 antibodies. Anti-PCNA antibodies were used to detect PCNA and
